GORDONMD GLOBAL - Key Persons


Andrew Yuen

Job Titles:
  • Senior Analyst
  • Senior Analyst at GordonMD® Global Investments LP
Andrew Yuen is the Senior Analyst at GordonMD® Global Investments LP. Prior to joining, Andrew was an Equity Research Associate for two years at The Capital Group with research responsibilities for U.S. and Japanese biotechnology and pharmaceutical companies.

Anthony Makdessi

Job Titles:
  • Research Associate
  • Research Associate at GordonMD® Global Investments LP
Anthony Makdessi is a Research Associate at GordonMD® Global Investments LP. Prior to joining, Anthony was a Fundamental Research Analyst at Causeway Capital Management for two years with research responsibilities for Global Healthcare companies focused on the pharmaceuticals sector.

Ashley Thomas

Job Titles:
  • Associate
  • Associate at GordonMD® Global Investments LP
Ashley Thomas is an Associate at GordonMD® Global Investments LP. Prior to joining, Ashley was a student at Colgate University. During her time at Colgate, she worked in a laboratory doing research on drug addiction, documented in her Senior Thesis. She has interned in a physician's office, held a summer position working in a Covid vaccination clinic and has worked for an emerging start up. She graduated Magna Cum Laude with a bachelor's degree in Neuroscience with a concentration in Global Public Health from Colgate University.

Craig D. Gordon - CEO, Chief Investment Officer, Founder

Job Titles:
  • Chief Executive Officer
  • Chief Investment Officer
  • Founder
  • Investment Manager
Prior to establishing GordonMD® Global Investments in 2021, Dr. Gordon worked at The Capital Group for 10+ years as an Equity Investment Analyst investing in and covering U.S. and Japanese biotechnology and pharmaceutical companies. In this capacity, he conducted research and built his own differentiated portfolio, taking into consideration numerous factors including but not limited to appropriate sizing, risk levels, and timing of milestones. Dr. Gordon worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate before joining Capital Group in 2010. In addition to being a licensed rheumatologist, Dr. Gordon is an investment manager, who has personally managed on average $7 billion or more, and provided help in overseeing additional portfolios totaling billions more.

Mike Kostolansky - COO

Job Titles:
  • COO
  • COO at GordonMD® Global Investments
Mike Kostolansky is the COO at GordonMD® Global Investments. Prior to joining the Firm, Mike was the COO/CFO at Rolnick Kramer Sadighi LLP ("RKS"), a litigation boutique. Prior to RKS, Mike spent more than 15 years as the COO, CFO, and CCO at several alternative asset managers spanning a wide variety of complex financial instruments and investment strategies. Mike also has experience as an Equity Analyst and Management Consultant. Mike earned a Bachelor's of Science in Chemical Engineering from Carnegie Mellon University and a Master in Business Administration from the University of Michigan.